Sign in
HOME
WESTCHESTER
FAIRFIELD
E-EDITIONS
FAIRFIELD
WESTCHESTER
ADVERTORIALS
INDUSTRIES
Real Estate
Economic Development
Hudson Valley
Courts
Arts & Leisure
Banking & Finance
Construction
Economic Development
Economy
Education
Energy
Food & Beverage
Government
Health Care
Hospitality & Tourism
Manufacturing
Mergers & Acquisitions
Nonprofits
Retail
Small Business
Technology
In America
Transportation
In the Family
VIDEOS
Video Interviews
EVENTS
2022 Doctors of Distinction
2022 C-SUITE AWARDS
PAST EVENTS
2022 FORTY UNDER 40
2022 THE FUTURE OF REAL ESTATE
2021 Milli + GenZ Awards
2021 DOCTORS OF DISTINCTION
2021 C-SUITE
2021 TOP WEALTH ADVISORS Virtual Event
2021 FORTY UNDER 40 VIRTUAL EVENT
BUSINESS EVENTS
MEMBERS
SUBSCRIBE
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, June 30, 2022
Sign in / Join
Advertise
Contact
My Account
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Westfair Communications
HOME
WESTCHESTER
FAIRFIELD
E-EDITIONS
FAIRFIELD
WESTCHESTER
ADVERTORIALS
INDUSTRIES
Real Estate
Economic Development
Hudson Valley
Courts
Arts & Leisure
Banking & Finance
Construction
Economic Development
Economy
Education
Energy
Food & Beverage
Government
Health Care
Hospitality & Tourism
Manufacturing
Mergers & Acquisitions
Nonprofits
Retail
Small Business
Technology
In America
Transportation
In the Family
VIDEOS
Video Interviews
EVENTS
2022 Doctors of Distinction
2022 C-SUITE AWARDS
PAST EVENTS
2022 FORTY UNDER 40
2022 THE FUTURE OF REAL ESTATE
2021 Milli + GenZ Awards
2021 DOCTORS OF DISTINCTION
2021 C-SUITE
2021 TOP WEALTH ADVISORS Virtual Event
2021 FORTY UNDER 40 VIRTUAL EVENT
BUSINESS EVENTS
MEMBERS
SUBSCRIBE
Home
Tags
Merimepodib
Tag: merimepodib
Fairfield
Westport’s ViralClear opens phase 2 clinical trial for COVID-19 drug
Kevin Zimmerman
-
June 18, 2020
Merimepodib demonstrated decreased viral production of COVID-19 by over 90%, and when combined with Gilead's remdesivir, to undetectable levels.
